GHK-Cu is a naturally occurring copper peptide that was first isolated from human plasma in 1973 by Dr. Loren Pickart. Dr. Pickart was studying the effects of copper on wound healing, and he discovered that GHK-Cu was particularly effective in stimulating collagen production and promoting wound closure.
In the years since its discovery, GHK-Cu has been the subject of extensive research, and its potential therapeutic applications have continued to grow. GHK-Cu has been shown to be effective in promoting wound healing, improving skin health, reducing hair loss, and protecting against age-related changes.
GHK-Cu is a small peptide that contains three amino acids: glycine, histidine, and lysine. The copper ion is bound to the histidine amino acid. This complex is thought to be responsible for many of the beneficial effects of GHK-Cu.
GHK-Cu works by interacting with a variety of cell receptors and signaling molecules. It has been shown to activate the fibroblast growth factor receptor (FGFR), which is a receptor that plays a key role in cell growth and repair. GHK-Cu also activates the production of collagen and other extracellular matrix proteins, which are essential for wound healing and skin health.
In addition to its effects on wound healing and skin health, GHK-Cu has also been shown to be effective in reducing hair loss and protecting against age-related changes. GHK-Cu stimulates the activity of hair follicles and prolongs the growing phase of the hair cycle. This can lead to thicker, fuller hair. GHK-Cu also protects cells from damage caused by free radicals and oxidative stress. Free radicals are unstable molecules that can damage cells and lead to aging. Oxidative stress is a condition that occurs when there is an imbalance between free radicals and antioxidants. Antioxidants are molecules that can neutralize free radicals and prevent cell damage.
GHK-Cu is a safe and effective compound that can be used to improve health and well-being. It is available in a variety of forms, including topical creams and serums, oral supplements, and injectable products.
Here is a brief timeline of the history of GHK-Cu research:
- 1973: GHK-Cu is first isolated from human plasma by Dr. Loren Pickart.
- 1970s: GHK-Cu is shown to promote wound healing and improve skin health in animal studies.
- 1980s: GHK-Cu is shown to be safe and effective in human clinical trials.
- 1990s: GHK-Cu is approved for use in a variety of cosmetic products.
- 2000s: GHK-Cu is shown to be effective in reducing hair loss and protecting against age-related changes.
- 2010s and beyond: GHK-Cu continues to be the subject of extensive research, and its potential therapeutic applications continue to grow.
GHK-Cu is a promising compound with a wide range of potential health benefits. More research is needed to confirm its safety and efficacy for the treatment of specific conditions in humans. However, the results of preclinical and clinical studies to date are encouraging.
